Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.00
Bid: 121.20
Ask: 122.00
Change: 1.60 (1.33%)
Spread: 0.80 (0.66%)
Open: 121.00
High: 122.00
Low: 120.40
Prev. Close: 120.40
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Gym Group directors sell GBP1.8 million in shares

Tue, 30th Mar 2021 16:01

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

Gym Group PLC - Croydon-based gym chain - Founder Director John Treharne sells 500,000 shares and Senior Independent Director Paul Gilbert sells 204,442 shares, both at 251.75 pence and together worth GBP1.8 million, on Monday. Treharne retains 2.1 million shares, while Gilbert sold his entire shareholding, as he is retiring from the board at the next annual general meeting.

----------

Anpario PLC - Nottinghamshire-based animal feed additives - Chief Executive Officer Richard Edwards sells 125,000 shares at 580p, worth GBP725,000, on Monday. Now has 88,396 shares, a 0.4% stake.

----------

NatWest Group PLC - Edinburgh-based lender - Robert Begbie, CEO of investment banking division NatWest Markets, sells 25,007 shares at GBP1.91, worth GBP47,791, on Monday.

----------

CVS Group PLC - Norfolk, England-based veterinary services - Non-Executive Director Richard Gray and wife Jennifer Gray buy 3,000 shares at 1,872 pence, worth GBP56,160. The purchase is Gray's only holding, having joined the CVS board in July last year.

----------

Syncona Ltd - investor in life science companies - Three non-executive directors - Virginia Holmes, Gianpiero Reverberi and Kemal Malik - buy 59,475 shares in total, at about GBP2.61 per share, worth GBP155,230, on Friday last week.

----------

Learning Technologies Group PLC - London-based digital learning services provider - Non-Executive Director Leslie-Ann Reed buys 100,000 shares at average GBP1.54, worth GBP154,000, on Monday. Reed now has 4.9 million shares, a 0.7% stake.

----------

Forterra PLC - Northampton, England-headquartered building products manufacturer - Chief Financial Officer Ben Guyatt sells 23,128 shares at GBP2.86, worth GBP66,249, while his spouse Wendy Guyatt buys 6,897 shares at GBP2.88, both on Monday. Guyatt now interested in 35,217 shares.

----------

LXi REIT PLC - London-based real estate investment trust - Non-Executive Director Colin Smith buys 25,000 shares at 122.3p, worth GBP30,575, on Monday. Now has 247,909 shares.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Dec 2021 12:24

Syncona portfolio firm Freeline cuts workforce and narrows focus

Syncona portfolio firm Freeline cuts workforce and narrows focus

Read more
29 Nov 2021 10:04

Syncona invests GBP19 million in Quell Therapeutics via funding round

Syncona invests GBP19 million in Quell Therapeutics via funding round

Read more
22 Nov 2021 15:57

EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan

EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan

Read more
11 Nov 2021 14:30

IN BRIEF: Syncona net assets drop as Life Science portfolio takes hit

IN BRIEF: Syncona net assets drop as Life Science portfolio takes hit

Read more
11 Nov 2021 09:42

Syncona net asset value slips in first half

(Sharecast News) - Healthcare investor Syncona reported net assets of £1.15bn at the end of its first half on Thursday, or 171.7p per share, down from £1.3bn or 193.8p per share at the end of March.

Read more
10 Nov 2021 10:51

Syncona's Freeline loss widens but progresses on Fabry's disease drug

Syncona's Freeline loss widens but progresses on Fabry's disease drug

Read more
10 Nov 2021 08:13

Syncona's Freeline makes progress in dose-finding trials

(Sharecast News) - Healthcare company Syncona announced new data from its portfolio company Freeline Therapeutics' ongoing phase 1 and 2 'MARVEL-1' dose-finding clinical trial of 'FLT190' for the treatment of Fabry disease on Wednesday, with the second patient dosed generating "encouraging" data.

Read more
9 Nov 2021 19:18

TRADING UPDATES: Sealand's China progress; Altus finds gold

TRADING UPDATES: Sealand's China progress; Altus finds gold

Read more
8 Nov 2021 09:37

Syncona's Autolus gets USD250 million investment from Blackstone

Syncona's Autolus gets USD250 million investment from Blackstone

Read more
4 Nov 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
3 Nov 2021 14:38

TRADING UPDATES: BATM signs new deal; Synectics wins two projects

TRADING UPDATES: BATM signs new deal; Synectics wins two projects

Read more
17 Aug 2021 11:33

Syncona focuses on portfolio as net asset value drops in first quarter

Syncona focuses on portfolio as net asset value drops in first quarter

Read more
16 Aug 2021 17:57

Syncona investee Freeline CEO Heggie leaves, COO Parini replaces

Syncona investee Freeline CEO Heggie leaves, COO Parini replaces

Read more
27 Jul 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Jun 2021 10:20

Syncona investee Anaveon doses first patient in ANV419 trial

Syncona investee Anaveon doses first patient in ANV419 trial

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.